McKesson Corp 2019 SR
The report highlights McKesson's corporate responsibility efforts for fiscal year 2019, focusing on product quality, patient safety, and environmental stewardship. Key achievements include completing 405 Six Sigma projects resulting in $160 million in cost savings and an 11% reduction in Scope 3 CO2 emissions from employee air travel. The company also launched the Foundation for Opioid Response Efforts (FORE) with a $100 million contribution to address the opioid crisis. Additionally, McKesson expanded its renewable energy use in Belgium and signed solar power agreements in the U.S. to reduce its carbon footprint.
Company: McKesson Corp
Sector: Health Care
Country: United States
Year: 2019
Type: SR
Pages: 36
McKesson Corp
Corporate Responsibility Report
The report highlights McKesson's corporate responsibility efforts for fiscal year 2019, focusing on product quality, patient safety, and environmental stewardship. Key achievements include completing 405 Six Sigma projects resulting in $160 million in cost savings and an 11% reduction in Scope 3 CO2 emissions from employee air travel. The company also launched the Foundation for Opioid Response Efforts (FORE) with a $100 million contribution to address the opioid crisis. Additionally, McKesson expanded its renewable energy use in Belgium and signed solar power agreements in the U.S. to reduce its carbon footprint.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Apr 1, 2018 - Mar 31, 2019
Fiscal Year
2019
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Water Consumption
Total Waste
Women on Board
Employees